| Application no. and date | 15823415.3 (espacenet) (Federated) (European Patent Register), 20151117 | | Patent/reg. no. and date | DK/EP 3220891, 20190724 | | Publication date | 20170927 | | Priority no. and date | US 201462083094 P, 20141121 | | EP pub. no. and date |
EP 3220891 20170927 | | Effective date | | | Applicant/owner | Biohaven Therapeutics Ltd., 215 Church Street
New Haven, CT 06510, US | | Applicant ref. no. | V152627DK | | Inventor | CORIC, Vladimir, 7 Richborough Road
Madison, CT 06443, US,
BERMAN, Robert, M., 77 Livingston Street
New Haven, CT 06511, US,
VLADYKA, Ronald, Samuel, 15 Norfolk Road
Somerst, NJ 08873, US,
SALEH, Amgad, K7 Quincy Circle
Dayton, NJ 08810, US,
YU, Danny, P.O. Box 1015
Somerville, MA 08876, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/428 (2006.01) , A61K 9/00 (2006.01) , A61K 9/08 (2006.01) , A61K 9/20 (2006.01) | | Title | SUBLINGUAL FORMULERING AF RILUZOL | | Int. application no. | US2015061114 | | Int. publication no. | WO2016081472 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
